MediWound Ltd

Industry · 14 registered clinical trials — 3 currently recruiting.

Status	Trial	Phase	Started
Recruiting	A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALU Venous Leg Ulcer (VLU)	Phase 3	2025-06-01
Not Yet Recruiting	Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Pl Venus Leg Ulcers	Phase 2	2025-04-30
Recruiting	A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma	Phase 1 / Phase 2	2021-06-30
Completed	A Study to Evaluate the Clinical Performance, Safety and Pharmacology Effect of EscharEx in Patients With Lowe Venous Leg Ulcer, Diabetic Foot Ulcer	Phase 2	2021-04-21
Completed	A Study to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg U Venous Leg Ulcer	Phase 2	2019-12-02
Completed	A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns Thermal Burns	Phase 3	2015-05-27
Completed	A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard o Thermal Burns	Phase 3	2015-05-01
Completed	Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds Hard to Heal Wounds, Venous Leg Ulcers, Diabetic Lower Extremity Ulcers	Phase 2	2014-07-24
Unknown	Functionality Assessments in Patients (Adults and Children) Following Treatment With Debrase Compared to Stand Burns, Upper Extremity, Burns, Lower Extremity	—	2013-03-01
Terminated	A Study, Performed in Subjects With Post Traumatic-post Surgical ,Venus Insufficiency and Diabetic Hard to Hea Surgical Wound Dehiscence	Phase 2	2012-11-01
Completed	Long Term Follow up of Scars Formation and Quality of Life Assessment Study Scars Formation, Quality of Life	—	2011-06-01
Completed	Feasibility Study: Enzymatic Debridement in Patients With Partial Thickness Burns Burn	Phase 2	2009-12-20
Completed	Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care Burn	Phase 3	2005-12-01
Approved For Marketing	Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries Thermal Burn	—	—